(WHS-P82) Optimizing Infection Prevention in MOHS Procedures: Efficacy of Intraincisional Antibiotic Prophylaxis and Future Research Directions
Friday, May 17, 2024
7:30 AM – 5:00 PM East Coast USA Time
Recent advancements in Mohs micrographic surgery (MOHS) procedures have demonstrated a significant reduction in the risk of postoperative infections through the implementation of novel practices. Notably, studies indicate that the use of incisional antibiotics has proven effective in decreasing the rate of surgical site infections associated with skin cancer surgery. Recent findings suggest that intraincisional antibiotic prophylaxis may offer a more efficient and localized method of infection prevention in MOHS procedures. While these emerging practices exhibit promise in reducing infection risks, further research is warranted to delve into the optimal strategies and specific agents for intraincisional antibiotic prophylaxis. Additional studies should explore the ideal timing, dosage, and duration of intraincisional antibiotic administration to maximize efficacy while minimizing potential adverse effects. Comparative analyses between intraincisional and systemic antibiotic prophylaxis could provide valuable insights into the most effective approach for different patient populations and surgical scenarios. Moreover, investigating the potential development of antibiotic resistance and the long-term implications of intraincisional prophylaxis is crucial to ensuring the sustainability and safety of these practices. This poster addresses the most recent findings regarding intraincisional antibiotic prophylaxis and explains the need for why further research is essential to address questions related to dosage, timing, and potential resistance development. Such investigations will contribute to refining guidelines for infection prevention in skin cancer surgery, ultimately enhancing patient outcomes and the overall success of MOHS procedures.